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Synthesis and cytotoxic analysis of some disodium
3,6-dihydroxysterol disulfates
Jianguo Cui , Hui Wang , Yanmin Huang , Yi Xin , Aimin Zhou
Introduction
In recent years, a variety of steroids with unusual and inter-
esting structures have been isolated from a wide range of marine
organisms, particularly from sponges and echinoderms [1–3].
Among these steroidal compounds, many are sulfated polyhy-
droxysterols in sodium salt forms [4,5]. These compounds have
exhibited a broad spectrum of biologic activities, such as sup-
pression of HIV replication [6–9], inhibition of protein tyrosine
kinases [10] and antitumor activities [11–13]. Therefore they
greatly attract the attention of organic chemists and biomedical
scientists [14–16]. Most of the sulfated polyhydroxysteroids iso-
lated from these echinoderms or ophiuroids are found that the
disulfation occurs on two hydroxyls located at C-2 and C-3 or
C-3 and C-7, or C-3 and C-21 [17]. In this report, we synthe-
sized three disulfated steroids with sulfate groups located at C-3
and C-6 on the ring A and B as shown in Fig. 1 and determined
their cytotoxicity against cancer cells. Interestingly we found that
the cytotoxicity of these compounds was differentially changed
along with the structure of the R group. Our finding provides
new evidence for the relationship between chemical structure and
biofunctions.
Results and discussion
Chemistry
The synthesis of sulfated 3,6-dihydroxysterol was based on
the methodology developed by Arnostova et al. [18]. Here
we present a more efficient method for the synthesis of dis-
odium 3,6-dihydroxysterol disulfates with a cholesterol-like or
stigmasterol-like or sitosterol-like side chain at position 17 [19,20].
As shown in Scheme 1, cholesterol, stigmasterol, and -sitosterol
were used as raw materials.
Compounds (4a–4c) were converted to the corresponding 4-en-
3, 6-dioxysteroids (5a–5c) via oxidation with PCC in CH2Cl2. The
reduction of 5a–5c by NaBH4 in the presence of NiCl2 gave 3,6-
dihydroxysteroids (6a–6c) according to the synthetic method we
previously developed [21]. The compounds 6a–6c presented a typ-
ical difference in their spectrum from their parent compounds
5a–5c. In the IR spectra the absorption at 1714 and 1686 cm−1 for
the original diketone carbonyl groups (CO) of 5b, was replaced by a
new broad absorption at 3427 cm−1 for 6b, indicating that the car-
bonyl groups in5bhadbeenchanged to thehydroxygroups in6b. In
addition, the double bond of 5b at 1609 cm−1 had been eliminated
in6b. In the 1HNMRspectrumthe chemical shifts at 3.650ppm(1H,
tt, J=11.0, 5.0, C3-H) and 3.803ppm (1H, dd, J=5.5, 2.5, C6-H) for
6b showed a -configuration of 3-H and 6-H.
Based on the synthetic method developed by Comin et al.
[14], the treatment of 6a–6c with triethylammonium-sulfur tri-
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24-Ethylcholest-4,22-dien-3,6-dione (5b): Yield: 83%, m.p.
134–135 ◦C; IR (KBr) : 2959, 1714, 1686, 1609, 969, 864 cm−1; 1H
NMR(CDCl3, 500MHz): 0.743(3H, s, 18-CH3), 0.805(3H, t, J=7.0,
29-CH3), 0.798(3H, d, J=6.5, 26- or 27-CH3), 0.849(3H, d, J=6.5,
26- or 27-CH3), 1.036(3H, d, J=7.0, 21-CH3), 1.169(3H, s, 19-CH3),
5.040(1H, dd, J=15.2, 9.0, C22-H), 5.150(1H, dd, J=15.2, 8.5, C23-H),
6.171(1H, s, C4-H).
24-Ethylcholest-4-en-3,6-dione (5c): Yield:86%,m.p. 172–174 ◦C.
IR (KBr) : 2959, 1683, 1601, 1581, 1461, 1377, 1246, 1124,
948, 871 cm−1; 1H NMR(CDCl3, 500MHz): 0.724(3H, s, 18-CH3),
0.816(3H, d, J=7.0, 26- or 27-CH3), 0.841(3H, d, J=7.0, 26- or 27-
CH3), 0.848(3H, t, J=8.0, 29-CH3), 0.935(3H, d, J=6.5, 21-CH3),
1.167(3H, s, 19-CH3), 2.13–2.17(1H, m, C2-H), 2.44–2.58 (2H, m,
C7-H and C2-H), 2.682(1H, dd, J=15.5, 4.5, C7-H), 6.170(1H, s,
C4-H).
The synthesis of compounds 6a–6c
Cholest-3ˇ,6ˇ-diol (6a): NaBH4 (90mg, 2.38mmol) was added
to a solution of 5a (200mg, 0.50mmol) and NiCl2.6H2O (120mg,
0.50mmol) in CH3OH (20mL) in 1min at room temperature. After
20min, the reaction was stopped. The solution was neutralized
with 1M HCl. After evaporating the majority of the MeOH under
reduced pressure, ethyl acetate (40mL) was added to the residue.
The resulting solution was washed with cold water and saturated
brines. After drying over anhydrous sodium sulfate, the solvent
was removed under reduced pressure, and the crude product was
thenpurifiedbyflash chromatographyon silica gel usingpetroleum
ether /ethyl acetate (1:1) as the eluent, to give 6a as a white solid
(164mg, 81%), m.p. 161–162 ◦C; IR(KBr) : 3399, 2925, 2868, 1470,
1360, 1319, 1172, 1078, 1041, 1021, 955, 767 cm−1; 1HNMR(CDCl3,
500MHz): 0.709(3H, S, 18-CH3), 0.878(3H, d, J=2.2, 26 or 27-CH3),
0.891(3H, d, J=2.2, 26 or 27-CH3), 0.927(3H, d, J=6.4, 21-CH3),
1.052(3H, s, 19-CH3), 3.64–3.82(1H, m, C3-H), 3.825(1H, d, J=2.4,
C6-H).
24-Ethylcholest-22-en-3ˇ,6ˇ-diol (6b): Yield: 72%; m.p.
207–209 ◦C; IR(KBr) : 3427, 2929, 2864, 1581, 1462, 1380,
1037, 967 cm−1; 1H NMR(CDCl3, 500MHz): 0.708(3H, s, 18-CH3),
0.795(3H, d, J=6.5, 26 or 27-CH3), 0.845(3H, d, J=6.5, 26 or
27-CH3), 0.802(3H, t, J=7.5, 29-CH3), 1.013(3H, d, J=7.0, 21-CH3),
1.033(3H, s, 19-CH3), 3.650(1H, tt, J=11.0, 5.0, C3-H), 3.803(1H,
dd, J=5.5, 2.5, C6-H), 5.022(1H, dd, J=15.0, 8.5, C22-H), 5.140(1H,
dd, J=15.0, 8.5, C23-H).
24-Ethylcholest-3ˇ,6ˇ-diol (6c): Yield: 72%; m.p. 172–173 ◦C;
IR(KBr) : 3419, 3125, 2941, 2872, 1397, 1172, 1033 cm−1; 1H
NMR(CDCl3, 500MHz): 0.728(3H, s, 18-CH3), 0.831(6H, d, J=7.6Hz,
26 and 27-CH3), 0.866(3H, d, J=6.2Hz, 29-CH3), 0.896(3H, s, 21-
CH3), 1.027(3H, s, 19-CH3), 3.667(1H, t, J=5.5, C3-H), 3.821(1H, s,
C6-H).
General procedure for the synthesis of compounds 1–3
Disodium 3ˇ,6ˇ-dihydroxy-5˛-cholestane disulfate (1): The
triethylamine-sulfur trioxide complex (173mg, 0.96mmol) was
added to a solution of cholest-3,6-diol (6a) (50mg, 0.12mmol)
in DMF (0.6mL) under an argon atmosphere, and the mixture was
stirred at 95 ◦C for 3h. Then the reaction mixture was quenched
with water (0.2mL). The solution was poured over a silica gel
column to remove excess SO3·NEt3. The product was eluted by
using petroleum ether /CH2Cl2 (1:1) as the eluent, and then con-
tinued to be eluted with MeOH/CHCl3(1:12), and followed by
evaporation of the solvent to yield a white solid (diammonium
3,6-dihydroxy-5-cholestane disulfate). To the solution of the
solid in methanol (15mL) was added Cation exchange resin 732
(sodium form) (Na+) (10g), and stirred for 5h at room temperature.
The resin was removed by filtration, and the filtrate was concen-
trated. This process was repeated one more time with 15g of the
resin. Finally compound 1was obtained as a colorless solid (45mg),
yield: 60%, m.p. 173–174 ◦C; IR(KBr) : 3464, 2937, 2868, 1470,
1383, 1226, 1066, 980, 947, 853, 820, 624 cm−1; 1H NMR(DMSO,
500MHz): 0.657(3H, s, 18-CH3), 0.851(3H, d, J=6.5, 26- or 27-CH3),
0.855(3H, d, J=6.5, 26- or 27-CH3), 0.896(3H, d, J=6.5, 21-CH3),
0.932(3H, s, 19-CH3), 1.935(1H, brd, J=12.5, C2-H), 3.966(1H, m,
C3-H), 4.140(1H, s, C6-H); 13C NMR(DMSO, 125MHz): 36.1(1-
C), 28.2(2-C), 70.1(3-C), 33.4(4-C), 35.4(5-C), 76.1(6-C), 42.8(7-C),
30.5(8-C), 47.7(9-C), 38.6(10-C), 21.1(11-C), 39.4(12-C), 40.6(13-C),
56.2(14-C), 24.4(15-C), 27.8(16-C), 54.2(17-C), 12.4(18-C), 15.8(19-
C), 35.6(20-C), 19.0(21-C), 36.1(22-C), 23.7(23-C), 40.5(24-C),
29.2(25-C), 22.8(26-C), 23.1(27-C); (-)LRESIMSm/z: 585[M−Na]−1,
563[M−2Na+H]−1.
Disodium 24-ethyl-3ˇ,6ˇ-dihydroxycholest-22-ene disulfate (2):
Yield: 66%; m.p. 174–175 ◦C; IR(KBr) v: 2937, 2864, 1646, 1466,
1368, 1209, 1066, 967, 853, 812 cm−1; 1H NMR(DMSO, 500Hz):
0.679(3H, s, 18-CH3), 0.778 (3H, t, J=4.4, 29-CH3), 0.795(3H,
d, J=6.1, 26- or 27-CH3), 0.835(3H, d, J=6.1, 26- or 27-CH3),
0.935(3H, s, 19-CH3), 0.998(3H, d, J=6.5, 21-CH3), 1.917(1H,
d, J=12.5, C2-H), 2.031(1H, m, C20-H), 3.961(1H, m, C3-H),
4.152(1H, d, J=3.4, C6-H), 5.031(1H, dd, J=15.1, 8.6, C22-H),
5.161(1H, dd, J=15.1, 8.8, C23-H); 13C NMR(DMSO, 125MHz):
35.5(1-C), 27.4(2-C), 70.1(3-C), 33.4(4-C), 31.8(5-C), 76.1(6-C),
45.7(7-C), 29.2(8-C), 54.2(9-C), 38.6(10-C), 21.4(11-C), 40.6(12-C),
44.2(13-C), 56.4(14-C), 25.3(15-C), 29.0(16-C), 56.0(17-C), 12.7(18-
C), 15.9(19-C), 42.6(20-C), 21.6(21-C), 138.6(22-C), 129.3(23-C),
47.8(24-C), 30.5(25-C), 21.1(26-C), 19.4(27-C), 24.4(28-C), 12.6(29-
C); (-)LRESIMS m/z: 611[M−Na]−1, 588[M−2Na]−2.
Disodium 24-ethyl-3ˇ,6ˇ-dihydroxycholestane disulfate (3):
Yield: 65%; m.p. 242–249 ◦C; IR(KBr) v: 3427, 2925, 1634, 1401,
1209, 815 cm−1; 1H NMR(DMSO, 500MHz): 0.650(3H, s, 18-CH3),
0.798(3H, d, J=7.0, 26- or 27-CH3), 0.818(3H, d, J=7.0, 26- or
27-CH3), 0.825(3H, t, J=6.5, 29-CH3), 0.896(3H, d, J=6.3, 21-CH3),
0.923(3H, s, 19-CH3), 1.924(1H, brad, J=12.5, C2-H), 3.961(1H, m,
C3-H), 4.181(1H, d, J=3.5, C6-H); (-)LRESIMS m/z: 613[M−Na]−1,
590[M−2Na]−2.
Assay for cell viability
Materials and methods
Stock solutionsof compounds1,2and3,wereprepared in sterile
dimethyl sulfoxide (DMSO) (Sigma) at a concentrationof 10mg/mL,
anddiluted toproper concentrations according to the experimental
design with the cell culture medium.
Cell culture
Sk-Hep-1, H-292, PC-3 (ATCC) and Hey-1B (a gift from Dr. Yan
Xu, University of Indiana) cells were cultured in a proper medium
supplemented with 10% fetal bovine serum and 0.1 g/L penicillin
G+0.1 g/L streptomycin sulfate in a humidified atmosphere of 5%
CO2 at 37 ◦C.
Treatment of cancer cells
Cancer cells (4×104 cells/mL, 200L) were seeded into each
well of a 96-well microtiter plate. After incubation for 24h, the
compounds with a series of concentrations (range 5–100g/mL)
were added to the cells. An equal amount of DMSO was added to
the cells as negative controls. All were treated in triplicate.
Determination of cell viability
MT Stetrazolium salt ((3-4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)
(CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay,
Cat #G5421, Promega Corporation) dye reduction assay was used
to determine the cell viability. The assay is dependent on the
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reduction of MTS by mitochondrial dehydrogenases of viable cells
to a blue water soluble formazan product, which can be measured
spectrophotometrically. The absorbance of the formazan product
at 490nm is in linear proportion to cell numbers. Briefly, after
treatment (see 3.4.3) with the compounds for 48h, the medium
was removed and the cells were incubated with 100L of fresh
medium plus 20L of MTS solution for additional 4h according
to the instruction provided by the manufacturer. The absorbance
(A) at 490nm was measured using a LD400 AD/LD analysis spec-
trometer (Beckman coulter). The IC50 value was calculated as the
concentration of drug yielding 50% cell survival.
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